Symptomatic relief of pain in patients with osteoarthritis or joint degenerative disease-causing synovial fluid dysfunction.
One injection once weekly for three consecutive weeks.
Patients with a history of hypersensitivity. Do not use if there is a skin infection or skin disease in the area to be injected. Do not use if the knee joint to be injected is in a state of severe infection or inflammation.
Not for ophthamic use. Avoid concomitant use with other intraarticular treatment. Pregnancy, lactation. Children. Elderly.
Joint discomfort, transient joint pain and inflammation.
Rare: Angioedema, facial flushing dyspnea, swelling, urticaria.
Concomitant use with quaternary ammonium salts ie., benzalkonium chloride may cause precipitation of hyaluronic acid.
M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of the musculo-skeletal system.
Atri Plus inj 1%
2 mL x 3 × 1's